HGH Fragment 176-191 5mg

HGH Fragment 176-191 5mg is a high-purity, research-grade synthetic peptide representing the C-terminal segment (amino acids 176–191) of human growth hormone. Developed exclusively for in-vitro and preclinical research, it is specifically engineered to support studies focused on lipolysis, fat metabolism, and adipocyte signaling pathways.

Unlike full-length growth hormone, HGH Fragment 176-191 is widely studied for its selective activity on fat metabolism without broader endocrine effects. Its targeted mechanism makes it a valuable compound for researchers investigating lipid oxidation, adipogenesis, and metabolic regulation in controlled laboratory environments.

Overview

HGH Fragment 176-191 5mg is recognized in research for its ability to interact specifically with lipolytic pathways. It is frequently utilized in studies exploring the breakdown of stored fat and inhibition of new fat formation at the cellular level.

Researchers focused on obesity biology, metabolic function, and adipose tissue dynamics rely on this peptide for its precision and reduced off-target activity. Its distinct profile allows for more focused investigations into fat metabolism compared to full-length growth hormone compounds.

Chemical Profile

Peptide Type: Growth hormone fragment (C-terminal)
Compound: HGH Fragment 176-191
Structure: Amino acids 176–191 of hGH
Primary Function: Lipolysis and fat metabolism research

Mechanism of Action

HGH Fragment 176-191 5mg is believed to function by targeting pathways involved in fat metabolism, particularly those regulating lipolysis and lipogenesis in adipose tissue.

Research suggests that it may stimulate the breakdown of stored fats while inhibiting the formation of new fat cells. These effects are associated with intracellular signaling mechanisms that influence adipocyte activity and lipid utilization, making it a key focus in metabolic research models.

Research and Experimental Applications

HGH Fragment 176-191 5mg is widely utilized in laboratory studies focused on:

• Lipolysis and fat oxidation research
• Adipogenesis and fat cell development studies
• Obesity and metabolic pathway analysis
• Lipid metabolism and energy utilization
• Adipocyte signaling and cellular response research
• Targeted fat metabolism investigations

Its selective activity makes it an essential compound for advanced fat metabolism and obesity-related research.

Why Researchers Choose HGH Fragment 176-191 5mg

• Selective targeting of lipolytic pathways
• Does not exhibit full-spectrum GH activity in research models
• High purity (≥99%) for reliable and reproducible results
• Ideal for adipose tissue and lipid metabolism studies
• Stable lyophilized form for flexible laboratory use
• Widely used in obesity and metabolic research applications

Additional Research Insights

In controlled research environments, HGH Fragment 176-191 has demonstrated strong activity in pathways associated with fat breakdown and metabolic regulation. Studies suggest that it may enhance lipid utilization while limiting fat accumulation at the cellular level.

Ongoing investigations continue to explore its role in energy balance, adipose tissue function, and metabolic efficiency, reinforcing its importance in modern obesity and lipid research.

Product Specifications

Product Name: HGH Fragment 176-191
Quantity: 5mg per vial
Form: Lyophilized powder
Purity: ≥99%

Storage Instructions

Store HGH Fragment 176-191 5mg in a cool, dry place away from direct light. Refrigeration is recommended to maintain stability, especially after reconstitution in research settings.

Important Notice

HGH Fragment 176-191 5mg is intended strictly for research and laboratory use only. It is not approved for human consumption, veterinary use, or therapeutic applications. All handling must be performed by qualified professionals in compliance with applicable laws and regulations.